Join Our Industry Symposia Program at DHCF 2026
*Industry Symposia are unaccredited sessions included with your registration. Please register for DHCF 2026 to attend these sessions.
GI/IBD Lunch Symposium 12:00 pm - 12:30 pm | Kitsilano ABC
Time for a VERDICT: Advancing the future of ulcerative colitis through optimal control
SPEAKER: Dr. Brian Bressler

Dr. Bressler is a Clinical Associate Professor of Medicine in the Department of Medicine at the University of British Columbia. Dr. Bressler is the Head of the Division of Gastroenterology at St Paul’s Hospital and the Lead Physician for the GI clinic of the Surgical Program at Providence Health Care. Dr. Bressler is the Co-Founder of the IBD Centre of BC and the Director of the Advanced IBD training program at the University of British Columbia. Dr. Bressler is a recognized expert in inflammatory bowel disease.
GI/IBD Break Symposium 10:15 am - 10:45 am | Kitsilano ABC
JAK as the new TNF - Chapter 2
A follow up on last year's symposium with updated data from LTE, RWE, and NMA sources that continue to build trust in the efficacy and safety of Rinvoq.
SPEAKER: Dr. Brian Bressler

Dr. Bressler received his MD from the University of British Columbia and completed his residency in internal medicine and gastroenterology at the University of Toronto. He received an MSc in epidemiology from the Harvard Public School of Health and completed an advanced fellowship in IBD at Massachusetts General Hospital, Harvard Medical School. In addition to his work at the IBD Centre of BC, Dr. Bressler is a Clinical Assistant Professor of Medicine in the Division of Gastroenterology at the University of British Columbia’s Department of Medicine. He is the founder of The IBD Centre of BC, the Director of UBC’s Advanced IBD training program and a world-recognized expert in inflammatory bowel disease. For more than 20 years, Dr. Bressler has dedicated himself to advancing research and care for British Columbians with Crohn’s disease and ulcerative colitis. With the creation of The IBD Centre of BC, Dr. Bressler and other specialists are carrying out his dream of providing IBD patients with timely, province-wide access to a multidisciplinary team of health-care professionals, advancing IBD research and providing world-class IBD education.
GI/IBD Lunch Symposium 12:00 pm - 12:30 pm | Kitsilano ABC
Complex IBD in Practice: Navigating Therapeutic Decisions Across the Patient Journey
As the treatment landscape for inflammatory bowel disease continues to evolve, gastroenterologists are increasingly challenged to make individualized treatment decisions for patients with complex disease. This symposium will explore practical approaches to navigating disease complexity, optimizing treatment strategies, incorporating evolving treatment goals and monitoring approaches, and managing patients with ongoing disease activity or disease-related complications. Through discussion of current evidence and its application in real-world practice, participants will gain actionable insights to support individualized, evidence-informed care for patients with Crohn's disease and ulcerative colitis.
SPEAKER: Dr. Brian Bressler

Brian Bressler MD, MSc, FRCPC Clinical Associate Professor of Medicine, University of British Columbia Dr. Bressler is a Clinical Associate Professor of Medicine in the Department of Medicine at the University of British Columbia. Dr. Bressler is a Staff Gastroenterologist at St. Paul's Hospital in Vancouver, Canada. Dr. Bressler is the Director of the Advanced IBD training program at the University of British Columbia. Dr. Bressler is a recognized expert in inflammatory bowel disease.
Liver Lunch Symposium 12:00 pm - 12:30 pm | Fairview III-V
Hep B Hotline: Evaluating Emerging Therapies on the Path to Functional Cure
Step into the clinic and watch each consult unfold as Dr. Tam assesses patient cases in real time. Together, you'll unpack the key updates from the 2025 Canadian CHB guidelines and navigate the evolving approach to CHB care. Dr. Tam will also evaluate the latest data on emerging treatments and explore which patients may be appropriate for these novel therapies.
SPEAKER: Dr. Edward Tam

Dr. Edward Tam is a Clinical Hepatologist at the Digestive Health Centre of BC. He has a full-time community-based clinical practice in General Hepatology with a focus on viral hepatitis, as well as an interest in steatotic liver disease and autoimmune liver diseases. He is active in teaching, clinical research, and clinical guidelines development. He has also published extensively in peer-reviewed journals and presented at international congresses. He currently serves on the executive board for the Canadian Association for the Study of the Liver as Secretary and Treasurer.



